Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Eser, A; Thalhammer, F; Burghuber, F; Högenauer, C; Stockenhuber, F; Wenisch, C; Widhalm, K; Reinisch, W.
Probiotics for the prevention of antibiotic-induced diarrhea].
Z Gastroenterol. 2012; 50(10):1089-1095
Doi: 10.1055/s-0032-1312950
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Hoegenauer Christoph
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Between 5 and 49% of patients treated with antibiotics suffer from diarrhoea. Principally all microbial agents can cause diarrhoea, especially oral agents like cephalosporines, clindamycin, broad-spectrum penicillins, and quinolones of the 3 rd and 4th generation. Manifestations of antibiotic-associated diarrhoea range from mild self-limiting forms to severe life-threatening courses. The potentially most severe form of antibiotic-associated diarrhoea is caused by Clostridium diffcile accounting for approx. 25 % of antibiotic-associated diarrhoea. In the past two decades a broad spectrum of different probiotic strains has been evaluated for the primary prevention of antibiotic-associated diarrhoea in children and adults. Based on their efficacy and clinical data, different levels of evidence and recommendations are emerging on the preventive use of probiotics in antibiotic-associated diarrhoea.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Anti-Bacterial Agents - adverse effects
- Child -
- Diarrhea - drug therapy
- Humans -
- Probiotics - therapeutic use
- Treatment Outcome -
- Find related publications in this database (Keywords)
- probiotics
- antibiotic-associated diarrhoea
- Clostridium difficile